eCas12f1 induced cell death in breast cancer cells by disrupting PLK1 and notably eCas12f1 effectively disrupted cancer-specific genes by recognizing BRAF mutations in the malignant melanoma cells. This evidence concerns the gene BRAF and breast cancer.